PRRT2 and glioma: It has long been known that in most cell types, one or more PKC isoforms influence the morphology of the F-actin cytoskeleton and overexpressed or hyperactive PKC is among the most distinguished characteristics of malignant central nervous system tumors including C6 or U-87 glioma cells [46,57].